These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 1848294)
21. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes. Watson M; Yamamura HI; Roeske WR J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580 [TBL] [Abstract][Full Text] [Related]
22. Amide, urea, and carbamate analogues of the muscarinic agent [4-[[N-(3-chlorophenyl)carbamoyl]oxy]-2-butynyl]trimethylammonium chloride. Nilsson BM; Vargas HM; Hacksell U J Med Chem; 1992 Jul; 35(15):2787-98. PubMed ID: 1379640 [TBL] [Abstract][Full Text] [Related]
23. Affinities of muscarinic drugs for [3H]N-methylscopolamine (NMS) and [3H]oxotremorine (OXO) binding to a mixture of M1-M4 muscarinic receptors: use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist, and antagonist classes. Sharif NA; Williams GW; DeSantis LM Neurochem Res; 1995 Jun; 20(6):669-74. PubMed ID: 7566362 [TBL] [Abstract][Full Text] [Related]
24. 6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors. Daly JW; Gupta TH; Padgett WL; Pei XF J Med Chem; 2000 Jun; 43(13):2514-22. PubMed ID: 10891110 [TBL] [Abstract][Full Text] [Related]
25. Binding characteristics and functional G protein coupling of muscarinic acetylcholine receptors in rat duodenum smooth muscle membranes. Liebmann C; Nawrath S; Schnittler M; Schubert H; Jakobs KH Naunyn Schmiedebergs Arch Pharmacol; 1992 Jan; 345(1):7-15. PubMed ID: 1538792 [TBL] [Abstract][Full Text] [Related]
26. Derivatives of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide. Nilsson BM; Ringdahl B; Hacksell U J Med Chem; 1988 Mar; 31(3):577-82. PubMed ID: 3346873 [TBL] [Abstract][Full Text] [Related]
27. Synthesis and muscarinic activities of quinuclidin-3-yltriazole and -tetrazole derivatives. Wadsworth HJ; Jenkins SM; Orlek BS; Cassidy F; Clark MS; Brown F; Riley GJ; Graves D; Hawkins J; Naylor CB J Med Chem; 1992 Apr; 35(7):1280-90. PubMed ID: 1560440 [TBL] [Abstract][Full Text] [Related]
28. The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex. Ehlert FJ; Jenden DJ Mol Pharmacol; 1985 Aug; 28(2):107-19. PubMed ID: 3839562 [TBL] [Abstract][Full Text] [Related]
29. Pharmacologic comparison of selected agonists for the M1 muscarinic receptor in transfected murine fibroblast cells (B82). Mei L; Lai J; Yamamura HI; Roeske WR J Pharmacol Exp Ther; 1991 Feb; 256(2):689-94. PubMed ID: 1704434 [TBL] [Abstract][Full Text] [Related]
30. Bretylium tosylate binds preferentially to muscarinic receptors labelled with [3H]oxotremorine M (SH or 'high affinity' receptors) in rat heart and brain cortex. Gillard M; Brunner F; Waelbroeck M; Svoboda M; Christophe J Eur J Pharmacol; 1989 Jan; 160(1):117-24. PubMed ID: 2714357 [TBL] [Abstract][Full Text] [Related]
31. Pharmacological differences between muscarinic receptors coupled to phosphoinositide turnover and those coupled to adenylate cyclase inhibition. Baumgold J; White T Biochem Pharmacol; 1989 May; 38(10):1605-16. PubMed ID: 2471534 [TBL] [Abstract][Full Text] [Related]
32. Differences between rat dorsal and ventral hippocampus in muscarinic receptor agonist binding and interaction with phospholipase C. Garcia Ruiz AJ; Zambelli M; La Porta C; Ladinsky H; Consolo S Eur J Pharmacol; 1993 Jan; 244(2):125-31. PubMed ID: 8432309 [TBL] [Abstract][Full Text] [Related]
33. Differences in ligand binding and phosphoinositide turnover between M1 muscarinic receptor gene transfected cells and mouse and rat brain membranes. Wang DX; Lerner-Marmarosh N; Sheu SS; Sharma V; Jou MJ; Abood LG Pharmacol Biochem Behav; 1994 Oct; 49(2):405-11. PubMed ID: 7824557 [TBL] [Abstract][Full Text] [Related]
34. Synthesis and muscarinic activities of 1,2,4-thiadiazoles. MacLeod AM; Baker R; Freedman SB; Patel S; Merchant KJ; Roe M; Saunders J J Med Chem; 1990 Jul; 33(7):2052-9. PubMed ID: 2362286 [TBL] [Abstract][Full Text] [Related]
35. Alkylating partial muscarinic agonists related to oxotremorine. N-[4-[(2-haloethyl)methylamino]-2-butynyl]-5-methyl-2-pyrrolidones. Ringdahl B; Roch M; Katz ED; Frankland MC J Med Chem; 1989 Mar; 32(3):659-63. PubMed ID: 2918515 [TBL] [Abstract][Full Text] [Related]
36. Discriminative stimulus properties of the muscarinic receptor agonists Lu 26-046 and O-Me-THPO in rats: evidence for involvement of different muscarinic receptor subtypes. Arnt J; Lembøl HL; Meier E; Pedersen H Eur J Pharmacol; 1992 Jul; 218(1):159-69. PubMed ID: 1397027 [TBL] [Abstract][Full Text] [Related]
37. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists. Gillard M; Waelbroeck M; Christophe J Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611 [TBL] [Abstract][Full Text] [Related]
38. Gallamine allosterically antagonizes muscarinic receptor-mediated inhibition of adenylate cyclase activity in the rat myocardium. Ehlert FJ J Pharmacol Exp Ther; 1988 Nov; 247(2):596-602. PubMed ID: 3183955 [TBL] [Abstract][Full Text] [Related]
39. Stereoselective binding and activity of oxotremorine analogs at muscarinic receptors in rat brain. Messer WS; Ngur DO; Abuh YF; Dokas LA; Ting SM; Hacksell U; Nilsson BM; Dunbar PG; Hoss W Chirality; 1992; 4(8):463-8. PubMed ID: 1476855 [TBL] [Abstract][Full Text] [Related]
40. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor. Olianas MC; Maullu C; Onali P Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]